Lysophosphatidic Acid Reduces Ischemic Brain Injury by Attenuating Vascular Permeability Through LPA4 Receptor Signaling
Translational Stroke Research · 2026-06 · 17 (3)
DOI: 10.1007/s12975-026-01451-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Stroke Research, online erschienen am 02.06.2026. Verfasst von Shintaro Yamada und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrative Vascular Biology, Faculty of Medical Sciences, University of Fukui, 23-3 Matsuoka-Shimoaizuki, Eiheiji, Yoshida, Fukui, 910…. Hauptthemen laut MEDLINE: Lysophospholipids, Receptors, Lysophosphatidic Acid, Capillary Permeability, Brain Ischemia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Fukui.
Abstract (Originalsprache)
Blood–brain barrier (BBB) disruption significantly exacerbates secondary injury following ischemic stroke. Although lysophosphatidic acid (LPA) is known to regulate vascular stability, its specific role in preserving BBB integrity during cerebral ischemia remains unclear. Here, we investigated the neuroprotective effects of LPA using a mouse model of distal middle cerebral artery occlusion (dMCAO). Eight- to ten-week-old female C57BL/6 mice received 10 mg/kg LPA intraperitoneally immediately after ischemia, and outcomes were assessed at 48 h after dMCAO via infarct volumetry, edema quantification, BBB permeability assays (Evans blue and FITC-dextran), and transcriptomic analyses. We demonstrate that LPA treatment significantly reduced infarct volume by approximately 60% and attenuated cerebral edema at 48 h post-ischemia; This protection was accompanied by preserved BBB integrity and maintained endothelial claudin-5 expression in the ischemic territory. Single-cell analysis identified selective and sustained expression of the LPA4 receptor in ischemic vascular endothelial cells. Crucially, the protective effects of LPA on infarct size and BBB permeability were abolished in LPA4 receptor-knockout mice. These findings indicate that LPA preserves BBB integrity and mitigates ischemic brain injury via an endothelial LPA4 receptor-dependent mechanism, identifying the LPA–LPA4 signaling axis as a promising therapeutic target for reducing secondary brain injury in ischemic stroke.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Integrative Vascular Biology, Faculty of Medical Sciences, University of Fukui, 23-3 Matsuoka-Shimoaizuki, Eiheiji, Yoshida, Fukui, 910-1193, Japan.
- Department of Neurosurgery, Division of Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, 910-1193, Japan.
- Tenure-Track Program for Innovative Research, University of Fukui, Fukui, 910-1193, Japan.
- Otothinolaryngology. Head & Neck Surgery, Faculty of Medicine, University of Fukui, Fukui, 910-1193, Japan.
- Department of Integrative Vascular Biology, Faculty of Medical Sciences, University of Fukui, 23-3 Matsuoka-Shimoaizuki, Eiheiji, Yoshida, Fukui, 910-1193, Japan. kidoya@u-fukui.ac.jp.
Förderung
- University of Fukui
Zitieren
APA
Yamada, S., Takara, K., Hosoe, N., Shimizu, A., Hayashi, Y., Lynda, L., Sonoda, T., Kikuta, K., & Kidoya, H. (2026). Lysophosphatidic Acid Reduces Ischemic Brain Injury by Attenuating Vascular Permeability Through LPA4 Receptor Signaling. Translational Stroke Research, 17(3). https://doi.org/10.1007/s12975-026-01451-8
Vancouver
Yamada S, Takara K, Hosoe N, Shimizu A, Hayashi Y, Lynda L, et al. Lysophosphatidic Acid Reduces Ischemic Brain Injury by Attenuating Vascular Permeability Through LPA4 Receptor Signaling. Translational Stroke Research. 2026;17(3). doi:10.1007/s12975-026-01451-8
BibTeX
@article{Yamada2026,
author = {Yamada, Shintaro and Takara, Kazuhiro and Hosoe, Naoi and Shimizu, Anna and Hayashi, Yumiko and Lynda, Lamri and Sonoda, Takayuki and Kikuta, Kenichiro and Kidoya, Hiroyasu},
title = {Lysophosphatidic Acid Reduces Ischemic Brain Injury by Attenuating Vascular Permeability Through LPA4 Receptor Signaling},
journal = {Translational Stroke Research},
year = {2026},
volume = {17},
number = {3},
doi = {10.1007/s12975-026-01451-8}
}
EUVIMED